Perfil
John Valliant is the founder of the Centre For Probe Development & Commercialization, holding the title of Independent Director & Principal Investigator since 2008.
Dr. Valliant was the founder of Fusion Pharmaceuticals, Inc., having held the title of Chief Executive Officer & Director from 2014 to 2024.
Dr. Valliant's current job is as a Professor at McMaster University, starting in 1999.
Dr. Valliant's education includes a doctorate from McMaster University.
Cargos activos de John Valliant
| Empresas | Cargo | Inicio |
|---|---|---|
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes radiopharmaceuticals for early diagnosis and treatment of diseases | Fundador | 01/03/2008 |
McMaster University
McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1999 |
Antiguos cargos conocidos de John Valliant.
| Empresas | Cargo | Fin |
|---|---|---|
| FUSN PHAR | Fundador | 04/06/2024 |
Formación de John Valliant.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
McMaster University
McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fusion Pharmaceuticals, Inc.
Fusion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals for the treatment of cancer | Health Technology |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes radiopharmaceuticals for early diagnosis and treatment of diseases | Health Technology |
- Bolsa de valores
- Insiders
- John Valliant
















